Clinical trials
Phase 3 Idiopathic Pulmonary Fibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
54 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 1 |
| 2003 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 3 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Terminated | 14 |
| Recruiting | 8 |
| Not yet recruiting | 3 |
| Active, not recruiting | 2 |
| Unknown status | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 5 |
| Genentech, Inc. | 4 |
| InterMune | 4 |
| Duke University | 3 |
| Hoffmann-La Roche | 3 |
| United Therapeutics | 3 |
| Actelion | 2 |
| Bristol-Myers Squibb | 2 |
| Gilead Sciences | 2 |
| Kyntra Bio | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Idiopathic Pulmonary Fibrosis | 54 |
| Pulmonary Fibrosis | 13 |
| Lung Diseases, Interstitial | 8 |
| Fibrosis | 5 |
| Lung Diseases | 4 |
| Cough | 2 |
| Hypertension, Pulmonary | 2 |
| Idiopathic Interstitial Pneumonias | 2 |
| Bronchiectasis | 1 |
| Cystic Fibrosis | 1 |
Trials
Showing 51 to 54 of 54. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.